BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 5:16:00 PM | Browse: 795 | Download: 669
Publication Name World Journal of Gastroenterology
Manuscript ID 7193
Country/Territory China
Received
2013-11-08 20:00
Peer-Review Started
2013-11-10 20:46
To Make the First Decision
2013-12-04 09:13
Return for Revision
2013-12-16 12:14
Revised
Second Decision
2014-03-19 13:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-19 15:23
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-05-14 18:37
Publish the Manuscript Online
2014-05-28 11:45
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Charing Ching Ning Chong, Grace Lai Hung Wong and Paul Bo San Lai
Funding Agency and Grant Number
Corresponding Author Charing Ching Ning Chong, MBChB, MSc, FCSHK, Division of Hepato-biliary and Pancreatic Surgery, Department of Surgery, Prince of Wales Hospital, the Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong, China. chongcn@surgery.cuhk.edu.hk
Key Words Antiviral therapy; Hepatitis B infection; Hepatocellular carcinoma; Hepatectomy; Liver resection; Outcome
Core Tip The impact of antiviral therapy on clinical outcomes after curative liver resection in patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) remains to be established. There are increasing evidence to suggest that antiviral therapy could suppress HBV replication, decrease the perioperative reactivation of virus, reduce liver injury, preserve the liver function before and after operation, and may lower the risk of HCC recurrence. Antiviral therapy may also improve the survival after liver resection by reducing recurrence and delaying the liver damage by the virus, rendering in a higher chance of receiving aggressive salvage therapy during HCC recurrence. We herein review the currently available evidences on this issue.
Publish Date 2014-05-28 11:45
Citation Chong CCN, Wong GLH, Lai PBS. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma. World J Gastroenterol 2014; 20(20): 6006-6012
URL http://www.wjgnet.com/1007-9327/full/v20/i20/6006.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i20.6006
Full Article (PDF) WJG-20-6006.pdf
Full Article (Word) WJG-20-6006.doc
Manuscript File 7193-Review.docx
Answering Reviewers 7193-Answering reviewers.pdf
Copyright License Agreement 7193-Copyright assignment.pdf
Peer-review Report 7193-Peer reviewer(s).pdf
Scientific Editor Work List 7193-Scientific editor work list.doc